Company
Zymeworks
Zymeworks has 6 drugs tracked on RxWires: 2 in Phase 2, 4 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Zanidatamab | Phase 2 | Breast Cancer |
| ZW25 | Phase 2 | Endometrial Cancer |
| ZW251 | Phase 1 | Hepatocellular Carcinoma |
| ZW191 | Phase 1 | Advanced Solid Tumors |
| ZW49 | Phase 1 | HER2-expressing Cancers |
| ZW171 | Phase 1 | Mesothelin-expressing Advanced Cancers |
Latest
Follow Zymeworks on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.